CryoLife/FDA Recall Negotiations Aimed At Pediatric Heart Valve Concerns
This article was originally published in The Gray Sheet
Executive Summary
CryoLife is discussing with FDA the possibility of amending the agency's Aug. 14 recall order of the company's reprocessed vascular and cardiac tissue